Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Illumina 2Q beats Street, outlook falls short
Yahoo/AP
Tuesday, July 26, 2011 - 9:59pm
tags:
earnings, Illumina
Celgene’s Blood-Cancer Treatment Backed by U.K. Cost Agency
Bloomberg
Tuesday, July 26, 2011 - 9:57pm
tags:
UK, Celgene, thalidomide, Multiple Myeloma
Medco, Astra get U.S. subpoenas over four drugs
Reuters
Tuesday, July 26, 2011 - 4:51pm
tags:
Medco, AstraZeneca, subpoena, Nexium, Prilosec, Toprol XL, Plendil
Takeda heads back to FDA with diabetes blockbuster hopeful
Fierce Biotech
Tuesday, July 26, 2011 - 4:43pm
tags:
FDA, diabetes, Takeda, alogliptin
Novo Nordisk hit with US lawsuit over overtime pay
Reuters
Tuesday, July 26, 2011 - 4:41pm
tags:
overtime lawsuits, Novo Nordisk
Qiagen's CEO Discusses Q2 2011 Results - Earnings Call Transcript
Seeking Alpha
Tuesday, July 26, 2011 - 4:40pm
tags:
Qiagen, earnings
Gilead second-quarter profit rises to $746.2 mln
Marketwatch
Tuesday, July 26, 2011 - 4:38pm
tags:
earnings, Gilead Sciences
Amylin Pharmaceuticals' CEO Discusses Q2 2011 Results - Earnings Call Transcript
Seeking Alpha
Tuesday, July 26, 2011 - 4:38pm
tags:
earnings, Amylin
Pfizer’s Zyvox and Antidepressants May Be Fatal Combination
Bloomberg
Tuesday, July 26, 2011 - 4:36pm
tags:
Pfizer, antidepressants, Zyvox, antibiotics, Pristiq, Eli Lilly, Zoloft, Cymbalta, GSK, Paxil, Wellbutrin
Earnings Preview: Bristol-Myers
Yahoo/Zacks.com
Tuesday, July 26, 2011 - 4:34pm
tags:
earnings, Bristol-Myers Squibb
Does Eli Lilly Miss the Grade?
Motley Fool
Tuesday, July 26, 2011 - 4:30pm
tags:
Eli Lilly
Biogen Earnings: Tysabri Sales Impress
TheStreet.com
Tuesday, July 26, 2011 - 1:59pm
tags:
Biogen Idec, earnings
Ligand trades higher on study of Promacta drug
Yahoo/AP
Tuesday, July 26, 2011 - 1:54pm
tags:
Promacta, Ligand, GSK, hepatitis C
Glaxo’s Product Pipeline Needs Priming
WSJ Online
Tuesday, July 26, 2011 - 1:40pm
tags:
GSK, pipelines, patents
Earnings Preview: Mylan Inc.
Yahoo/Zacks.com
Tuesday, July 26, 2011 - 11:10am
tags:
earnings, Mylan
Watson Pharmaceuticals 2Q profit dips 25 percent
Yahoo/AP
Tuesday, July 26, 2011 - 10:44am
tags:
Watson Pharmaceuticals, earnings
GlaxoSmithKline cost-cutting drives $1.8 billion profit in second quarter; Japan sales strong
Yahoo/AP
Tuesday, July 26, 2011 - 10:42am
tags:
GSK, earnings
Specialty Drugs Entice BTG While Awaiting Varicose-Vein Medicine
Bloomberg
Tuesday, July 26, 2011 - 10:40am
tags:
varicose vein, BTG
Conflict-of-Interest Rules May Be Relaxed in 2012, Hamburg Says
Bloomberg
Monday, July 25, 2011 - 7:40pm
tags:
FDA, conflict-of-interest, Peggy Hamburg, physician payments
Pharmasset research costs climb in 3Q loss
Yahoo/AP
Monday, July 25, 2011 - 7:38pm
tags:
Pharmasset, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.